Effect of BMS-663068 on the Pharmacokinetics of Rosuvastatin

Trial Profile

Effect of BMS-663068 on the Pharmacokinetics of Rosuvastatin

Phase of Trial: Phase I

Latest Information Update: 24 Apr 2018

At a glance

  • Drugs Fostemsavir (Primary) ; Rosuvastatin
  • Indications HIV-1 infections
  • Focus Pharmacokinetics
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 25 Feb 2016 Results presented at the 23rd Conference on Retroviruses and Opportunistic Infections
    • 09 Feb 2015 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
    • 12 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top